420 with CNW — Feds Fund Central Research Center to Combat Barriers to Cannabis Research

Recently, the National Institutes of Health posted a funding opportunity notice stating that it sought an eligible body to operate a new center for marijuana and cannabinoid research via a cooperative agreement. The centralized cannabis research center would be designed to help researchers overcome barriers to studying cannabis amid federal prohibition. This is in addition to allowing scientists to generate more scientific evidence across various research domains in clinical and basic research.

Addressing barriers in cannabis research has been a priority for many federal health agencies as researchers continue to be subjected to costly and taxing registration processes in order to access marijuana for research. This is primarily because of the drug’s current status under the Controlled Substances Act.

The NIH noted that ultimately, the research center could facilitate advancements in research through interactions among experts in relevant clinical, commercial, regulatory and basic science areas, both within the research center itself and jointly with other researchers that possess diverse expertise and research backgrounds.

The NIH also outlined central components of the center’s objectives, including  research standards, research support and regulatory guidance. On the regulatory front, the center would be charged with organizing meetings with the DEA and/or FDA to obtain updates on regulatory information, among other tasks. On the research standards front, the center would be responsible for the development of research metrics and standards that enhance the rigor of chemical analysis of complex marijuana products to improve research reproducibility, among other functions.

With regard to research support, the research center could identify and circulate early career reviewer opportunities under the NIH, administer seed funding and use social media to transmit scientific information, among other functions. Agencies under the NIH that will occupy supportive roles in the center’s work include the National Center for Complementary and Integrative Health, the National Cancer Institute, the National Institute on Aging and the National Institute on Drug Abuse.

Interested parties must elaborate how they propose to achieve the stipulated objectives, which involve the creation of a clearing house for existing research guidance, developing best practices, organizing meetings with the FDA and the DEA, standardizing research methodologies, circulating relevant scientific literature on marijuana and apportioning seed funding to support research initiatives.

Institutions that are invited to submit applications include nonprofit organizations, universities and local and federal government agencies, among others. The deadline for letters of intent is March 16, 2023, which is also when applications will start being accepted.

If this new research facility works as intended, cannabis industry actors such as Green Thumb Industries Inc. (CSE: GTII) (OTCQX: GTBIF) could sooner or later see a decrease in some of the hurdles they face in studying marijuana.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive SMS alerts from CNW, text CANNABIS to 844-397-5787 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Study Says Male Cannabis Users Are at Lower Risk for Kidney Stones

A recent study suggests that men who regularly use cannabis have a lower likelihood of experiencing kidney stones. Researchers who analyzed data spanning from 2009 to 2018, sourced from the National Health and Nutrition Examination Survey (NHANES), found that male cannabis users exhibited a significant 28% decrease in the odds of reporting kidney stones compared to nonusers.

Furthermore, research showed that men who used cannabis between one and seven times per week had even more favorable odds, with a substantial 38% reduction in the likelihood of kidney stones. Those who used cannabis more than seven times per week did not experience a decrease in kidney stone risk. No connection was established between marijuana use and kidney stones among women.

The authors stated that this was the first study to examine the link between cannabis use and the risk of kidney stones using data from the population-based NHANES data set to its knowledge.

The study included a total of 14,323 participants between the ages of 20 and 59, all of whom had a comprehensive history of kidney stones and cannabis use. Approximately 26% of these individuals reported using marijuana at some point in their lives, and the incidence rate of kidney stones stood at 7.8%.

The researchers noted that due to the cross-sectional design of the NHANES data set, it was not possible to establish a causal relationship between cannabis use and kidney stones. Additionally, the data on cannabis use was self-reported, lacking specifics regarding the type and dosage of cannabis.

Dr. David Goldfarb, New York University Langone Health Kidney Stone Prevention program director and nephrology chief, didn’t participate in the study, but he did comment on it, noting that “the study appears to be well-executed, and the data seem reliable.” He did, however, point out that the study did not provide a clear explanation for the observed effect in men and the lack of an effect in women.

Goldfarb also found it surprising that using marijuana more than seven times per week did not yield further reductions in the risk of kidney stones. He raised the question of whether the mode of consumption, specifically edibles, which have gained popularity in the United States, might have a similar impact on risk.

The study, carried out by Xin Wei, MD, and her colleagues from West China Hospital, Sichuan University in Chengdu, China, was published in “Frontiers in Pharmacology.”

This study shows that there is still much more being discovered about the health benefits of cannabis, and enterprises such as Green Thumb Industries Inc. (CSE: GTII) (OTCQX: GTBIF) may be selling recreational and medical marijuana products that provide more benefits to their customers than previously realized.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive SMS alerts from CNW, text CANNABIS to 844-397-5787 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Company Hopes Breathalyzer Will Curb Workplace Marijuana Use

California-based biotechnology company Hounds Lab has developed a first-of-its-kind breathalyzer with the ability to accurately detect cannabis use. The first model works by preserving breath samples and sending them to the lab for chemical analysis. However, the company is developing a second model that can deliver test results on scene.

According to Hound Lab’s chairman of the board Mike Lynn, the company learned via extensive testing that smoked cannabis will trigger a 100% positive result within an hour of smoking, but the positivity rate declines to around 85% at two hours.

Cannabis testing has been a contentious issue across the United States as dozens of states have legalized recreational or medical cannabis despite ongoing federal prohibition. Although many employers weren’t happy with the fact that their employees may be using cannabis, especially federal employees and those in safety-related positions, properly enforcing cannabis requirements was nigh impossible.

While we have standardized and relatively accurate tests for alcohol, there is no test that can accurately determine if and when an individual used cannabis or whether they are still affected by the drug at the moment of testing. With dozens of states legalizing the controversial plant, law enforcement and some employers have called for proper cannabis tests to facilitate proper enforcement of driving and workplace drug policies.

The new test represents a breakthrough that could finally provide an accurate means of testing for cannabis and curbing workplace cannabis use. Lynn says the Hound Cannabis Breathalyzer took close to a decade of engineering and science to develop. He calls the breathalyzer the “first and only” commercially available breath-based test that can help employers limit cannabis use at the workplace without penalizing their employees for using cannabis during their free time. Ideally, Lynn notes, the breathalyzer test should allow workers to use state-legal cannabis during their off hours just as they would consume alcohol without fear of reprisal by their employers.

Although Hound Labs will first market the cannabis breathalyzer to employers, it hopes other industries such as law enforcement will use the technology in the future. Lynn explains that the compny will be better equipped to serve law enforcement once federal and state governments define standards for cannabis law enforcement.

More than 20 states and nearly 40 states now allow recreational and medical cannabis respectively, meaning millions of employees across the country now have access to legal cannabis. As such, an effective system for testing whether or not employees are under the influence of cannabis while on the job will be critical to curbing workplace cannabis use.

Such a testing tool would likely gain the support of industry actors such as Green Thumb Industries Inc. (CSE: GTII) (OTCQX: GTBIF) since such testing equipment would eliminate cases of people who have been wrongly accused of being under the influence because they consumed cannabis off hours.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive SMS alerts from CNW, text CANNABIS to 844-397-5787 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Could Marijuana Rescheduling Result in Nationwide Legalization?

The discussion surrounding the legalization of cannabis has remained a prominent topic in recent times, with several states choosing to take matters into their own hands by legalizing it within their borders rather than waiting for federal intervention. However, there is now a glimmer of hope on the federal front as health officials have recommended marijuana reclassification, potentially signaling a significant stride toward nationwide legalization.

Unfortunately, this isn’t as straightforward as it may appear.

Currently, marijuana is categorized as a Schedule I drug, a classification that implies the DEA deems it as lacking a recognized medical purpose and having a substantial potential for abuse. However, the United States Department of Health and Human Services shared its findings on cannabis with the U.S. Drug Enforcement Administration (DEA) and recommended that it be classified as a Schedule III substance. According to this classification, the drug has a low to moderate risk of causing physical and mental dependence. Comparable drugs in Schedule III include anabolic steroids and ketamine.

While the recommendation may sound promising, the status quo for marijuana remains largely unaffected. The DEA will require a considerable amount of time to deliberate and decide on the reclassification. In addition, even if reclassified, cannabis would still fall under the purview of federal regulations, remaining a controlled substance. Importantly, it does not instantaneously translate into federal legalization for recreational use and does not decriminalize the substance.

Nevertheless, the reclassification of cannabis could bring about some positive changes. For example, it would pave the way for increased research opportunities since studying Schedule III drugs is less restrictive compared to Schedule I. Additionally, it might lead to a reduction in the federal taxes levied on cannabis businesses. Under the current tax code, enterprises dealing with Schedule I and II substances cannot claim deductions for expenses such as payroll or rent, resulting in high tax rates for cannabis companies.

Presently, about 23 states have legalized recreational cannabis, while 38 states have legalized it for medical purposes. The latest additions to this list are Missouri, Maryland, Connecticut, New York and Rhode Island.

The potential repercussions of cannabis reclassification in these states remain uncertain. Natacha Andrews, who serves as the executive director of the National Association of Black Marijuana Lawyers, suggests that it could potentially disrupt state programs, stating, “The state-level legalization goes against the established order. The ambiguity surrounding the DEA’s next steps raises numerous questions, with some states experiencing minimal disruptions while others encounter more significant issues.”

The cannabis industry, together with its leading enterprises such as Green Thumb Industries Inc. (CSE: GTII) (OTCQX: GTBIF), would appreciate cannabis policy reforms at the federal level that ease some of the complications companies have to navigate as they stay compliant with state law while also keeping federal law in mind.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive SMS alerts from CNW, text CANNABIS to 844-397-5787 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Wyoming Activists Consider Court Action Against Government Official Regarding Stand on Marijuana Voter Measure

Activists behind two cannabis reform measures in Wyoming are considering seeking legal action against the secretary of state over a voter-signature disagreement. According to the campaign, Secretary of State Chuck Gary’s office “provided incorrect information” on the number of signatures activists had to submit for their measure to qualify for the 2024 ballot.

The Compassionate Options Wyoming, the state Libertarian Party and Wyoming NORML says the misunderstanding has turned into a time-consuming back-and-forth that has derailed the marijuana reform measures and prompted them to consider litigation. Both measures would legalize medical cannabis in Wyoming and decriminalize simple possession of small amounts of marijuana.

In a recent press release, activists claimed that the secretary of state’s office had instructed them to collect more than 40,000 signatures for their measure to qualify for the ballot even though state law only called for 29,730 signatures. The cannabis measures would have qualified under the rules requiring slightly under 30,000 signatures; instead, both measures failed to qualify for the ballot earlier this year.

Wyoming NORML announced in March that although it had collected enough raw signatures for both initiatives, the group didn’t meet the minimum percentages needed in two-thirds of the counties in Wyoming. The activists collected 47,426 signatures for the cannabis decriminalization proposal and 48,687 signatures for the medical marijuana proposal but clarified at the time that the signatures were not state verified.

Reform activist and Oquirrh Mountain Strategies consultant Apollo Pazell said the disagreement stemmed from a dispute on when and how the secretary of state’s office determined the signature thresholds for measures to qualify for the ballot. According to Pazell, the campaign reached out to the office on several occasions but was “given the turnaround.” Pazell also notes that a state website showed that the minimum threshold for ballot initiatives to qualify was 41,776, but number changed to 29,000 the day after the campaign’s deadline passed.

Conversely, Secretary of State Gary says Pazell’s claims are untrue and an attempt to shift blame onto the office for not doing enough due diligence. Gary explained that the campaign began collecting signatures 15 months before he took office, and any incorrect information the organizations received would have come from the previous administration’s election team.

Wyoming is one of the few states in the country that still outlaws both medical and recreational cannabis. Reform activists tried to qualify a cannabis measure for the 2022 ballot but were unable to collect enough signatures due to the coronavirus pandemic and poor weather.

As the calls for reform in Wyoming become louder, a time will come when this outlier state on matters of marijuana policy also eventually opens up and allows local enterprises akin to Green Thumb Industries Inc. (CSE: GTII) (OTCQX: GTBIF) to mushroom and thrive within its borders.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive SMS alerts from CNW, text CANNABIS to 844-397-5787 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Brazilian Study Suggests Cannabis Helps Against Autism

With emerging research showing that cannabis holds promise for various health conditions, it comes as no surprise that some scientists have started conducting research on the drug’s usefulness in managing autism. Global researchers estimate that about 1% of the total population worldwide suffer from autism. However, few patients receive diagnoses, with many going about their daily lives undiagnosed.

Now new research by a team of scientists in Brazil has made a new discovery concerning the use of cannabis extracts in managing autism.

This isn’t the first study to evaluate this link, as a number of separate studies have also noted improvements in patients with autism who consume either the cannabis flower or plant-derived extracts.  For instance, survey data published two years ago by the “Autism Parenting” Magazine cited that 22% of parents or caregivers in the United States had given CBD to an autistic child.

For their study, the researchers in Brazil evaluated the use of personally tailored doses of full-spectrum cannabis extracts in 20 patients living with autism spectrum disorder. Roughly 80% of the patients consumed these extracts, which were either dominant in THC or CBD, for a period of no less than six months. To personalize these THC and CBD dosages, the researchers used a titration protocol. It should be noted that all dosages were taken orally.

The researchers linked the cannabis treatment to perceived improvements in autism symptoms, as well as reductions in the use of neuropsychiatric drugs prescribed to the patients.  In their report, the researchers stated that during the three to twenty-one months of treatment using cannabis extracts, parents of patients involved in the study reported improvements. They added that as treatment continued, the doses of most other drugs being taken were reduced or were totally eliminated during the treatment period.

The researchers noted that the majority of patients and their families noted an improvement in quality of life, adding that the side effects observed from the treatment were primarily temporary and mild.

In their conclusion, the researchers highlighted that their study expanded the scientific data that demonstrated that the use of cannabis extracts clinically was a safe intervention with valuable and promising effects over many aspects of autism that weren’t achieved by conventional drugs. The researchers added that based on their findings, they proposed guidelines for personalized treatment regimens that could be adapted to locally available and qualified full-spectrum cannabis extracts and help advance clinical trials.

The researchers’ findings were published in the “Frontiers in Psychiatry” journal.

This research suggests that the full potential of the medical marijuana products sold by companies such as Green Thumb Industries Inc. (CSE: GTII) (OTCQX: GTBIF) hasn’t been fully documented. As more becomes known about the additional conditions that marijuana can help with, the number of people who look to this substance for relief will keep growing.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive SMS alerts from CNW, text CANNABIS to 844-397-5787 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Key Senate Committee Chair Promises to Advance Cannabis Banking Bill

The chairman of a key Senate committee has revealed that he discussed the possibility of advancing bipartisan cannabis banking legislation within the next six weeks with Senate Majority Leader Chuck Schumer. During a recent interview with Punchbowl News, Senate Banking Committee chair Sherrod Brown said that he talked to Schumer about moving the Secure and Fair Enforcement (SAFE) Banking Act alongside several other major bills within the next one and a half months.

Cannabis banking has been a contentious issue since states began legalizing medical and recreational cannabis in the United States nearly two decades ago. Although dozens of states now have legal cannabis programs, federal law still classifies marijuana as a Schedule I drug with no medical application. As a result of federal prohibition, licensed cannabis operators find it nigh impossible to access critical financial services such as banking, cashless payments, capital and financial aid.

This forces cannabis businesses to operate on a mostly cash-only basis and puts these businesses at significant risk of violent robberies, something that has been occurring in recent months with increasing frequency. The SAFE Banking Act was introduced to address the lack of access to financial services in America’s multibillion-dollar cannabis industry.

In a recent floor speech and in a letter to fellow lawmakers, Schumer said providing the cannabis industry with access to banking is a priority. He noted that although “making progress on cannabis” via banking legislation was a legislative priority, the legislation wouldn’t progress on the Senate floor without bipartisan support on cannabis reform and related issues, including capping insulin prices and competing with China on the global scale. Additionally, spending legislation will take up a lot of the Senators’ time in the next few weeks, likely reducing the time they have to discuss cannabis banking.

One key section of the SAFE Banking Act (Section 10) has also been subject to intense debate among lawmakers in recent months and even prevented the measure from passing during the summer legislative session.

In late July, Schumer said lawmakers having bipartisan negotiations over the SAFE Banking Act were “making good progress.” The Senate Majority leader reportedly told a lobbyist at the time that Senate lawmakers were working on cannabis banking. He had previously stated that he wished to address marijuana banking reform during the summer session but constant debate over sections of the cannabis banking bill have kept the measure from advancing until the end of the session.

The marijuana industry and its leading entities such as Green Thumb Industries Inc. (CSE: GTII) (OTCQX: GTBIF) have heard such promises before and are unlikely to get too excited by these new pronouncements until actual banking reform is enacted at the federal level.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive SMS alerts from CNW, text CANNABIS to 844-397-5787 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — DeSantis Reaffirms Opposition to Federal Cannabis Legalization

Ron DeSantis, the Florida governor and a contender for the 2024 presidential election on the Republican ticket, has restated his firm stance against the legalization of marijuana if he were to assume office. His argument asserts that the legalization of marijuana has contributed to the growth of the illegal market in Colorado — despite evidence to the contrary.

While engaging with supporters during a campaign event in Iowa over the weekend, a concerned attendee shared stories of individuals whose children had developed cannabis-induced psychosis. The individual queried DeSantis about his position on legalizing or rescheduling cannabis at the federal level should he ascend to the presidency. DeSantis responded, reiterating his unwavering stance against legalization, echoing viewpoints he had expressed in a similar vein back in June.

The conversation then shifted toward a broader discourse on the negative consequences of substance abuse. DeSantis highlighted the existence of an unregulated drug market in San Francisco, using it as an example to underscore his belief that prevailing policies have contributed to the deterioration of society by enabling drug use.

DeSantis acknowledged the existence of medical cannabis access in Florida through a voter-approved constitutional amendment. However, he emphasized that different states have handled cannabis regulation differently, and he expressed his disinclination to further increase its accessibility under his leadership.

The fate of cannabis legalization in Florida might not solely rely on DeSantis’s stance, as the state Supreme Court is currently deliberating on the inclusion of a marijuana legalization initiative on the 2024 ballot.

Although DeSantis didn’t substantiate his argument with data or references, various government and private analyses suggest that Colorado has witnessed a considerable reduction in illicit market influence since implementing legalization. Notably, a report by Whitney Economics and Leafly from the previous year indicated that the regulated industry accounts for 99% of adult-use cannabis sales in Colorado, signifying a successful transition from the illicit market.

Recent data from the city of Denver further bolstered the case for legalization. The report indicated a significant decrease in law enforcement’s handling of illegal marijuana in 2022, providing tangible evidence of legalization’s effectiveness in curbing illicit sales.

DeSantis’s opposition to marijuana legalization, despite a growing bipartisan trend in support of reform, is consistent with his historical stance. This standpoint is only one aspect of his multifaceted position on the matter, as he competes to maintain his position as the second-leading candidate in the Republican presidential nomination race.

On a policy level, DeSantis signed a bill that recently came into effect in Florida, imposing stricter regulations on medical marijuana advertising and manufacturing. The law prohibits any promotional content related to “recreational” marijuana use while also imposing more rigorous eligibility criteria for individuals working in the cannabis industry. Additionally, DeSantis signed a bill in June that prevents residents of sober living facilities from possessing or using medical marijuana, even if they possess a doctor’s certification for therapeutic use. This restriction does not extend to other doctor-prescribed medications.

In the same month, the governor enacted legislation prohibiting the sale of consumable hemp products, including cannabis-infused chewing gum, to individuals under the age of 21. This expanded the existing restriction on the purchase of smokable hemp by young individuals.

DeSantis’ opposition to federal cannabis legalization suggests that it may still take a while for politicians on Capitol Hill to enact federal drug policy reforms that align with the wishes of the people, just in the same way that the current U.S. president hasn’t pushed for major reforms as had been expected when he was elected. Countrywide cannabis legalization as enjoyed by companies such as Green Thumb Industries Inc. (CSE: GTII) (OTCQX: GTBIF) in Canada is still a dream for American enterprises.

About CannabisNewsWire

CannabisNewsWire (“CNW”) is a specialized communications platform with a focus on cannabis news and the cannabis sector. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled recognition and brand awareness. CNW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from CNW, text CANNABIS to 844-397-5787 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

CannabisNewsAudio – Cannabis Strategic Ventures, Inc. (NUGS) Investing in California’s Booming Cultivation Market

Related Editorial
California continues to be the leading center for the U.S. cannabis industry, with huge growth already taking place and plenty of potential for more.

Cannabis Strategic Ventures (OTCQB: NUGS) (NUGS Profile) is among the growing number of California cannabis companies boasting multiple cultivation, manufacturing and distribution licenses. Its wholly owned and operated flagship farm, NUGS FARM, recently completed its first harvest. Like Cannabis Strategic Ventures, Acreage Holdings Inc. (OTCQX: ACRGF) is invested up and down the supply chain, with new brands targeting markets in California and elsewhere. Green Thumb Industries Inc. (CSE: GTII) (OTCQX: GTBIF) recently announced expansion in Pennsylvania, catering to the state’s 180,000 registered cannabis users. Halo Labs Inc. (OTCQX: AGEEF) provides vital support services to the California market, using cutting-edge technology to extract active ingredients from cannabis. Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) has financed a fresh wave of expansion through a sale-and-leaseback agreement on its existing cultivation properties.

To hear the CannabisNewsAudio version, visit http://cnw.fm/fZ13B

To view the full editorial, visit http://cnw.fm/T1CCq

About Cannabis Strategic Ventures

Cannabis Strategic Ventures is on a mission to shape the cannabis industry by striving for constant evolution in products, process, and people. The Los Angeles-based company incubates, develops and partners with category leaders within the cannabis and ancillary sectors. As one of the largest publicly traded cannabis cultivators in the United States, the Cannabis Strategic Ventures portfolio includes NUGS FARM, a 6-acre greenhouse operation with full cultivation, manufacturing and distribution licenses; Asher House Wellness a is a line of ingestible Pet CBD products that contains a broad spectrum of beneficial hemp; The Cloud is a dispensary, cultivation, and manufacturing facility located in the heart of downtown Los Angeles. For more information, visit the company’s website at www.CannabisStrategic.com.

NOTE TO INVESTORS: The latest news and updates relating to NUGS are available in the company’s newsroom at http://cnw.fm/NUGS

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

Californian Cannabis Industry Blazes Trail of Growth for US

CannabisNewsWire Editorial Coverage: California continues to be the leading center for the U.S. cannabis industry, with huge growth already taking place and plenty of potential for more.

Cannabis Strategic Ventures (OTCQB: NUGS) (NUGS Profile) is among the growing number of California cannabis companies boasting multiple cultivation, manufacturing and distribution licenses. Its wholly owned and operated flagship farm, NUGS FARM, recently completed its first harvest. Like Cannabis Strategic Ventures, Acreage Holdings Inc. (OTCQX: ACRGF) is invested up and down the supply chain, with new brands targeting markets in California and elsewhere. Green Thumb Industries Inc. (CSE: GTII) (OTCQX: GTBIF) recently announced expansion in Pennsylvania, catering to the state’s 180,000 registered cannabis users. Halo Labs Inc. (OTCQX: AGEEF) provides vital support services to the California market, using cutting-edge technology to extract active ingredients from cannabis. Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) has financed a fresh wave of expansion through a sale-and-leaseback agreement on its existing cultivation properties.

  • California’s industry is expected to be worth $3.1 billion this year and could reach more than three times this size as it takes over from the illegal market.
  • Public companies are expanding thanks to support from the state and ancillary businesses.
  • Federal legislation keeps many of these companies from stock exchange listings, so they are traded as over-the-counter shares.
  • Cultivation operations provide the bedrock for their growth.

To view an infographic of this editorial, click here.

California Leads the Way for Cannabis Industry

As with many other significant economic and social changes, California is currently leading the way in the legal cannabis market. The first state to legalize medical cannabis has created a whole new sector of the legal economy and continues to set the standard that the rest of the market follows. The words cannabis and California go hand in hand.

The fall harvest is approaching, highlighting how much cannabis cultivation in California has thrived. Growing consumer demand in both the medical and recreational cannabis segments has led to constant growth for the industry. Consumers want more and better cannabis, and companies are moving to meet that demand. Cannabis investment is rising as companies realize the potential rewards of investing in cannabis.

Maturing Industry Makes More Cannabis Stocks Available

Investors both inside and outside California have been turning their attention to the state’s cannabis industry. These investors are flocking to pick up stocks in cannabis-related enterprises such as Cannabis Strategic Ventures (OTCQB: NUGS), a cannabis-related holding company that has recently made significant investments in the Californian cultivation market.

The early days of the cannabis industry were uncertain ones for investors. Though California had taken the bold step of legalizing the medical cannabis industry, the shape of that industry and the profitability of companies remained uncertain. Questions about how the federal government would respond, given that this state-level legislation was at odds with federal laws shaped by the war on drugs, contributed to that uncertainty. Further changes such as the legalization of cannabis in California for recreational purposes, which happened only three years ago, have meant ongoing uncertainty and adaptation.

In-state progress has made positioned companies such as Cannabis Strategic Ventures for success. The state has a fully regulated market, with licensing arrangements for the production, processing and sale of cannabis. Sophisticated infrastructure is emerging to nurture the industry, both in the government machinery that regulates it and in the businesses that provide materials and services.

The result is a growing number of public companies, some new and others well established. Investors have a range of options to choose from and greater confidence than ever before that their money is in safe hands.

California’s Billion-Dollar Cannabis Industry

The central driver for growth is the high demand for cannabis that exists in California. The state’s legal cannabis industry is expected to reach $3.1 billion in sales this year, according to a report from research firms Arcview Market Research and BDS Analytics. This expected demand has fueled spectacular growth in the number and scale of cultivation operations, as new ones enter the market every year. Cannabis Strategic Ventures’ NUGS FARM site made its first sales this September and is building toward its full operational capacity for the start of next year. Others are in similar positions, gearing up from first sales to big cultivation and sales operations.

These sales are likely to increase as more of the state’s shadow market in cannabis moves into the light. Illegal operations in California are estimated to be worth $8.7 billion this year. The state is working to eradicate these operations and create a safer, better-regulated market that will protect consumers, workers and well-run businesses.

Operations such as NUGS FARM are both a result of and a contribution to the erosion of the illegal market. As police crack down on illegal operations, customers move toward legal outlets to obtain their drugs. In addition, the existence of legal outlets is itself a draw away from the illegal sellers. By providing a safe, legal way for customers to obtain what they’re looking for, with more consistent results and value for money, enforcement agencies are eroding the illegal market’s customer base.

Investing in Cannabis Off the Exchanges

Despite this, many cannabis companies are unable to list their stocks on American exchanges. Instead, the likes of Cannabis Strategic Ventures are traded as over-the-counter stocks on OTC Markets.

The reason behind this is federal legislation. Though many states have changed their views, the United States government still treats cannabis as a Schedule One drug, legally regarded to be as dangerous as heroin or LSD, despite the overwhelming scientific evidence against this stance. This means that companies that directly cultivate and sell recreational cannabis are barred from listing on U.S. financial exchanges. Some ancillary and biotech companies have found a way around this and onto the exchanges, while others have been listed in Canada instead. But for many, over-the-counter sales between traders remain the way forward.

The Practicalities of Cannabis Cultivation

Despite the challenge this situation creates, there is no shortage of funding for cannabis growers. For the first time, investors are starting to learn what a cannabis cultivation project looks like.

Many of these operations are based on indoor growing, which allows for greater security and consistency of results. NUGS FARM is a 6.5-acre greenhouse operation, using specialized farming equipment to feed, water and monitor the plants. The farm has licenses to cultivate, manufacture and distribute cannabis, giving Cannabis Strategic Ventures the right to be involved in and provide quality control through the entire supply chain. NUGS can produce tens of thousands of pounds of cannabis annually, with the plants coming from the company’s own unique, high-quality flower strains. NUGS has started booking sales of this produce as it gears up to full capacity in early 2020.

This is the shape of the Californian cannabis industry — sophisticated, forward looking and constantly expanding. Challenges such as the illegal market and federal regulations are being overcome — or even turned to the industry’s advantage.

All In On Cannabis

Across the 33 states in which medical or recreational cannabis is now legal, companies are enjoying similar patterns of expansion.

Starting with its founder’s investment in a cannabis license in Maine eight years ago, Acreage Holdings Inc. (OTCQX: ACRGF) has since expanded to create a company operating in states across the United States. A team of experts with experience in everything from legislation to healthcare to cultivation, the company is invested all along the supply chain, from cultivation to manufacturing to dispensing to branding. Acreage Holdings recently rolled out a new set of products under its House of Brands strategy. California is among the target markets for these products, tapping into that large and growing customer base.

Green Thumb Industries Inc. (CSE: GTII) (OTCQX: GTBIF) is another multistate operator with cultivation centers in a number of states. The company is focused on the medical rather than the recreational sector of the market, focusing on the health benefits that cannabis can bring. Green Thumb Industries recently opened its seventh retail store in Pennsylvania, a sizeable market with 180,000 in-state registered medical cannabis patients. Such moves have led to a tripling in Green Thumb’s revenues in the second quarter of this year.

The industry isn’t just about cultivation and retail; there’s a large base of support services backing that. Among those companies is Halo Labs Inc. (OTCQX: AGEEF), which specializes in the extraction of active ingredients from cannabis. This extraction allows the chemicals to be used in products ranging from medicines to vaping liquid to food and drink. Halo’s leading-edge technology gives it an advantage in the extraction market, a fast-moving segment based on swiftly changing technology. Halo Labs was recently awarded two new licenses for operations in California, where it already has a 9,400-square-foot campus dedicated to the processing of cannabis products.

A vertically integrated company working across the United States, Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) is one of the leading multistate cannabis companies. Cresco deals with the whole supply chain of cannabis, including cultivation, processing, packaging, shipping and sales in its own dispensaries. The company recently made a sale-and-leaseback deal on two of its cultivation properties in Illinois to provide extra funds for expansion in the state. Like California, Illinois has plenty of room for expansion, and the industry there is expected to eventually reach $2 to $4 billion in value. The deal will position Cresco to make the most of that growth.

The cannabis industry is growing in many states, following the lead of California, where a powerful market is forging the way ahead for the rest of the country.

For more information on Cannabis Strategic Ventures, visit Cannabis Strategic Ventures Inc. (NUGS)

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by CNW are solely those of CNW. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW for any investment decisions by their readers or subscribers. CNW is a news dissemination and financial marketing solutions provider and is NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.

CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and CNW undertakes no obligation to update such statements.